Markets | | | The equity markets have seen unprecedented volatility in 2020 triggered by the COVID-19 pandemic black swan event. The S&P 500 ETF (NYSEARCA: SPY) has broken all kinds of records including the fastest drop into a bear market in history collapsing in excess of (-30 percent) from highs in just thr... Read the Full Story |
|
From Our PartnersSimple Options Trading for Beginners retails on Amazon for $19.95 and has 4 out of 5 stars. It was written by a stock market trading veteran with over 44 years of experience. Because of a special promotion, this book is 100% FREE for you today. | | So get it here now... |
|
Markets | | | Sell The Rumor, Buy The News
JonesTrading Chief Market Strategies Mike O’Rourke says we are on the brink of Bear-Maggedon. Bear-Maggedon, to him, is the toxic-combination economic-rollover in the face of easy money policy. In this environment, investors will begin to fear the Fed’s abil... Read the Full Story |
|
Stocks | | | Even as the major indices have been setting records for intra-day and intra-week swings and volatility reaches never before seen heights, there are some stocks, who by their mechanics, are destined to move even faster. Read the Full Story |
|
From Our PartnersToday, we are inviting you to take a free peek at our proprietary, exclusive and up-to-the-minute list of [link]20 stocks that Wall Street's top analysts think won't survive the current crisis[/link].
These are true "Strong Sell" stocks.
Many of these appear to have good fundamentals and might seem like okay investments as recently as a week ago, but something is wrong. Analysts smell something seriously rotten about these companies.
Sell-side analysts may not have a 100% hit rate on their buy ratings, but they almost always are spot on when they throw red flags and issue "sell" ratings.
If any of these stocks are lurking around in your portfolio, you may seriously want to consider dumping them before COVID-19 gets much worse. | | Click Here to View the Stocks |
|
Markets | | |
Sometimes, when market volatility is on the rise, finding places that can protect your money and avoid downside risk is huge. One of the crucial things to understand about investing is that risk is always a possibility. If you look at the recent volatility in the market, you might be wondering whe... Read the Full Story |
|
Markets | | | The storied history of Bitcoin (BTC) reveals how the very first block aptly referred to as the Genesis Block, was mined by its anonymous creator Satoshi Nakamoto on January 3, 2009. On that Genesis Block was the inscription, “The Times 03/Jan/2009 Chancellor on bringing of the second bailout f... Read the Full Story |
|
From Our PartnersThis hidden income strategy was just leaked and it can be yours now. It goes in depth about how you can start off with a small account and turn that into your own weekly paycheck. Learn how you can GAIN that extra advantage over what others aren't doing. | | Click here to get this secret |
|
The Early Bird Stock Of The Day NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida. | | View Today's Stock Pick |
|
